Cullinan Therapeutics, Inc.
(CGEM - NASDAQ)
13,25 USD
📋 Profilo Aziendale

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies.

|